FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2949280637> ?p ?o ?g. }

• W2949280637 endingPage "106564" @default.
• W2949280637 startingPage "106564" @default.
• W2949280637 abstract "Hypovitaminosis D represents an emerging cardiovascular risk factor, and especially among higher-risk subsets of patients, such as in those with diabetes mellitus. The anti-inflammatory and anti-thrombotic properties of vitamin D, in fact, could be even more beneficial among diabetics, where platelet hyperreactivity and suboptimal response to antiplatelet drugs has been associated with poorer outcomes. However, no study has so far evaluated the impact of vitamin D levels on platelet reactivity and high-on treatment platelet reactivity (HRPR) among diabetic patients receiving dial antiplatelet therapy (DAPT). Our population is represented by a consecutive cohort ofdiabetic patients treated with DAPT (ASA + clopidogrel or ticagrelor or dose-adjusted prasugrel) for an acute coronary syndrome or elective PCI, undergoing platelet reactivity assessment at 30–90 days post-discharge. Aggregation was assessed by multiple-electrode aggregometry. HRPR was defined for values above the lower limit of normality (in non-treated patients). We included 440 patients, that were divided according to quartiles values of vitamin D (< 9.4; 9.4–15.59; 15.6–21.64; ≥ 21.65 ng/ml). Among them, 31 were excluded as chronically treated with vitamin D supplementation. Lower vitamin D quartiles were associated with more advanced age (p = 0.01), female gender (p = 0.04), renal failure (p = 0.005), history of previous MI (p = 0.01), CABG and use of diuretics (p = 0.003), severe coronary disease (p = 0.002), but lower ejection fraction (p = 0.001), treatment with statins (p = 0.04) and new ADP-antagonists (p = 0.002). Vitamin D levels related with higher HbA1c (p = 0.001), cholesterol (p = 0.02) and creatinine (p = 0.004) and lower hemoglobin (p = 0.004). The prevalence of HRPR with ASA was low and not related to vitamin D quartiles (3.4% vs 2.7% vs 1.8% vs 2.1%, p = 0.44; adjusted OR[95%CI] = 1.16[0.60–2.26], p = 0.67). The prevalence of HRPR for ADP antagonists was associated to hypovitaminosis D (40.2% vs 29.1% vs 29.4% vs 25.5%, p = 0.03; (adjusted OR[95%CI] = 1.76[1.04–2.98], p = 0.036for I vs II-IV quartile). The impact of vitamin D quartiles, was significant only in patients on new ADP antagonists (n = 225, of whom 81 on prasugrel 5 mg; p = 0.03; adjusted OR[95%CI] = 3.12[1.34–7.49], p = 0.009) but not with clopidogrel (p = 0.85, adjusted OR[95%CI] = 1.05[0.49–2.24], p = 0.89). Among diabetic patients receiving dual antiplatelet therapy for an acute coronary syndrome or elective percutaneous coronary intervention, severe vitamin D deficiency is associated with a higher ADP-mediated platelet reactivity and rate of HRPR, and especially for new ADP-antagonists over clopidogrel." @default.
• W2949280637 created "2019-06-27" @default.
• W2949280637 creator A5002885109 @default.
• W2949280637 creator A5010855327 @default.
• W2949280637 creator A5015479782 @default.
• W2949280637 creator A5037008118 @default.
• W2949280637 creator A5047328504 @default.
• W2949280637 creator A5058341072 @default.
• W2949280637 creator A5067778460 @default.
• W2949280637 creator A5068649190 @default.
• W2949280637 creator A5073420948 @default.
• W2949280637 creator A5084842406 @default.
• W2949280637 date "2019-09-01" @default.
• W2949280637 modified "2023-10-14" @default.
• W2949280637 title "Vitamin D levels and platelet reactivity in diabetic patients receiving dual antiplatelet therapy" @default.
• W2949280637 cites W1927574886 @default.
• W2949280637 cites W1971231499 @default.
• W2949280637 cites W1973368497 @default.
• W2949280637 cites W1979949191 @default.
• W2949280637 cites W1981084145 @default.
• W2949280637 cites W1981990797 @default.
• W2949280637 cites W1990018236 @default.
• W2949280637 cites W1990144565 @default.
• W2949280637 cites W2004227110 @default.
• W2949280637 cites W2020099275 @default.
• W2949280637 cites W2023266656 @default.
• W2949280637 cites W2024577345 @default.
• W2949280637 cites W2032167693 @default.
• W2949280637 cites W2032570695 @default.
• W2949280637 cites W2035139971 @default.
• W2949280637 cites W2035827787 @default.
• W2949280637 cites W2046664111 @default.
• W2949280637 cites W2065036350 @default.
• W2949280637 cites W2075943636 @default.
• W2949280637 cites W2084673482 @default.
• W2949280637 cites W2087387326 @default.
• W2949280637 cites W2088939881 @default.
• W2949280637 cites W2092533999 @default.
• W2949280637 cites W2093125083 @default.
• W2949280637 cites W2097137681 @default.
• W2949280637 cites W2099022345 @default.
• W2949280637 cites W2104969665 @default.
• W2949280637 cites W2113936359 @default.
• W2949280637 cites W2114396884 @default.
• W2949280637 cites W2124070987 @default.
• W2949280637 cites W2127984785 @default.
• W2949280637 cites W2138058610 @default.
• W2949280637 cites W2140501627 @default.
• W2949280637 cites W2149175313 @default.
• W2949280637 cites W2157011913 @default.
• W2949280637 cites W2161785946 @default.
• W2949280637 cites W2161887684 @default.
• W2949280637 cites W2171792003 @default.
• W2949280637 cites W2293477021 @default.
• W2949280637 cites W2316112497 @default.
• W2949280637 cites W2317601097 @default.
• W2949280637 cites W2345294515 @default.
• W2949280637 cites W239948102 @default.
• W2949280637 cites W2405974214 @default.
• W2949280637 cites W2510902864 @default.
• W2949280637 cites W2563026406 @default.
• W2949280637 cites W2616730536 @default.
• W2949280637 cites W2752033985 @default.
• W2949280637 cites W2781567091 @default.
• W2949280637 cites W2783531203 @default.
• W2949280637 cites W4376848313 @default.
• W2949280637 cites W47455383 @default.
• W2949280637 doi "https://doi.org/10.1016/j.vph.2019.106564" @default.
• W2949280637 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31176855" @default.
• W2949280637 hasPublicationYear "2019" @default.
• W2949280637 type Work @default.
• W2949280637 sameAs 2949280637 @default.
• W2949280637 citedByCount "12" @default.
• W2949280637 countsByYear W29492806372020 @default.
• W2949280637 countsByYear W29492806372021 @default.
• W2949280637 countsByYear W29492806372022 @default.
• W2949280637 countsByYear W29492806372023 @default.
• W2949280637 crossrefType "journal-article" @default.
• W2949280637 hasAuthorship W2949280637A5002885109 @default.
• W2949280637 hasAuthorship W2949280637A5010855327 @default.
• W2949280637 hasAuthorship W2949280637A5015479782 @default.
• W2949280637 hasAuthorship W2949280637A5037008118 @default.
• W2949280637 hasAuthorship W2949280637A5047328504 @default.
• W2949280637 hasAuthorship W2949280637A5058341072 @default.
• W2949280637 hasAuthorship W2949280637A5067778460 @default.
• W2949280637 hasAuthorship W2949280637A5068649190 @default.
• W2949280637 hasAuthorship W2949280637A5073420948 @default.
• W2949280637 hasAuthorship W2949280637A5084842406 @default.
• W2949280637 hasConcept C124490489 @default.
• W2949280637 hasConcept C126322002 @default.
• W2949280637 hasConcept C134018914 @default.
• W2949280637 hasConcept C164705383 @default.
• W2949280637 hasConcept C2777028646 @default.
• W2949280637 hasConcept C2777628954 @default.
• W2949280637 hasConcept C2777698277 @default.
• W2949280637 hasConcept C2777849778 @default.
• W2949280637 hasConcept C2780890252 @default.
• W2949280637 hasConcept C2908647359 @default.

• next